 DURHAM, N.C., Nov. 05, 2020 GLOBE NEWSWIRE -- Chimerix NASDAQ:CMRX, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Mike Sherman, Chief Executive Officer, will present a corporate overview and program update at the Credit Suisse 29th Annual Healthcare Conference on Thursday, November 12, 2020 at 4:15 p.m. ET. 